Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...
Eli Lilly and Company (NYSE: LLY) announced on February 23, 2026, that the U.S. Food and Drug Administration has approved a label expansion for Zepbound, its blockbuster obesity drug, to include a new ...
About a month after securing a label expansion from the FDA for multidose pen versions of Zepbound, Eli Lilly is making the KwikPens available to self-paying users of its direct-to-consumer drug sales ...
Eli Lilly received approval from the Food and Drug Administration for a label expansion of its weight-loss drug Zepbound, adding a new monthly delivery option for patients. The pharmaceutical company ...
Lilly’s momentum isn’t just about its successful clinical results, though. It’s also about the company’s constant iteration ...
Please provide your email address to receive an email when new articles are posted on . The Zepbound KwikPen allows patients to receive four doses of the drug in a single pen device. According to Eli ...
Kroger said it is now stocking Eli Lilly's injection pen version of the weight-loss drug Zepbound, and will allow self-pay customers to use Lilly's savings card at its retail pharmacies. The ...
Eli Lilly LLY0.80%increase; green up pointing triangle received approval from the Food and Drug Administration for a label expansion of its weight-loss drug Zepbound, adding a new monthly delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results